These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 27338969)

  • 1. Hallucinogen Use Disorders.
    Hardaway R; Schweitzer J; Suzuki J
    Child Adolesc Psychiatr Clin N Am; 2016 Jul; 25(3):489-96. PubMed ID: 27338969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hallucinogen-induced psychological disorders].
    Hermle L; Kovar KA; Hewer W; Ruchsow M
    Fortschr Neurol Psychiatr; 2008 Jun; 76(6):334-42. PubMed ID: 18512184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features and management of intoxication due to hallucinogenic drugs.
    Leikin JB; Krantz AJ; Zell-Kanter M; Barkin RL; Hryhorczuk DO
    Med Toxicol Adverse Drug Exp; 1989; 4(5):324-50. PubMed ID: 2682130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous polysubstance use among Danish 3,4-methylenedioxymethamphetamine and hallucinogen users: combination patterns and proposed biological bases.
    Licht CL; Christoffersen M; Okholm M; Damgaard L; Fink-Jensen A; Knudsen GM; Erritzoe D
    Hum Psychopharmacol; 2012 Jul; 27(4):352-63. PubMed ID: 22696164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does getting high hurt? Characterization of cases of LSD and psilocybin-containing mushroom exposures to national poison centers between 2000 and 2016.
    Leonard JB; Anderson B; Klein-Schwartz W
    J Psychopharmacol; 2018 Dec; 32(12):1286-1294. PubMed ID: 30182795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adolescent and adult time trends in US hallucinogen use, 2002-19: any use, and use of ecstasy, LSD and PCP.
    Livne O; Shmulewitz D; Walsh C; Hasin DS
    Addiction; 2022 Dec; 117(12):3099-3109. PubMed ID: 35978453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of hallucinogen abuse.
    Haddad LM
    Am Fam Physician; 1976 Jul; 14(1):82-7. PubMed ID: 1065215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hallucinogen use among young adults ages 19-30 in the United States: Changes from 2018 to 2021.
    Keyes KM; Patrick ME
    Addiction; 2023 Dec; 118(12):2449-2454. PubMed ID: 37287110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Who takes the trip? Personality and hallucinogen use among college students and adolescents.
    Parnes JE; Kentopp SD; Conner BT; Rebecca RA
    Drug Alcohol Depend; 2020 Dec; 217():108263. PubMed ID: 32932162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Consumption of psilocybin-containing hallucinogenic mushrooms by young people].
    Lassen JF; Lassen NF; Skov J
    Ugeskr Laeger; 1992 Sep; 154(39):2678-81. PubMed ID: 1413197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hallucinogen use disorders among adult users of MDMA and other hallucinogens.
    Wu LT; Ringwalt CL; Mannelli P; Patkar AA
    Am J Addict; 2008; 17(5):354-63. PubMed ID: 18770077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between individual hallucinogens and hallucinogen misuse among U.S. Adults who recently initiated hallucinogen use.
    Jones G; Herrmann F; Wang E
    Addict Behav Rep; 2023 Dec; 18():100513. PubMed ID: 37649653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hallucinogen abuse].
    Angst J
    Schweiz Med Wochenschr; 1970 Apr; 100(16):710-5. PubMed ID: 5524824
    [No Abstract]   [Full Text] [Related]  

  • 14. 5-Year trends in use of hallucinogens and other adjunct drugs among UK dance drug users.
    McCambridge J; Winstock A; Hunt N; Mitcheson L
    Eur Addict Res; 2007; 13(1):57-64. PubMed ID: 17172780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward a typology of hallucinogen users in the United States.
    Salas-Wright CP; Hodges JC; Hai AH; Alsolami A; Vaughn MG
    Drug Alcohol Depend; 2021 Dec; 229(Pt B):109139. PubMed ID: 34781182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hallucinogenic mushrooms popular again--sale via Internet].
    Westberg U; Karlson-Stiber C
    Lakartidningen; 1999 Feb; 96(7):746-7. PubMed ID: 10087778
    [No Abstract]   [Full Text] [Related]  

  • 17. Differences in the stimulus properties of 3,4-methylenedioxyamphetamine and 3,4- methylenedioxymethamphetamine in animals trained to discriminate hallucinogens from saline.
    Callahan PM; Appel JB
    J Pharmacol Exp Ther; 1988 Sep; 246(3):866-70. PubMed ID: 2901488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psilocybin--summary of knowledge and new perspectives.
    Tylš F; Páleníček T; Horáček J
    Eur Neuropsychopharmacol; 2014 Mar; 24(3):342-56. PubMed ID: 24444771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bromo-DMA: the Australasian hallucinogen?
    Buhrich N; Morris G; Cook G
    Aust N Z J Psychiatry; 1983 Sep; 17(3):275-9. PubMed ID: 6580896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Jimson weed abuse in an Oklahoma teen.
    Honey BL; Hagemann TM; Lobb KM; McGoodwin L
    J Okla State Med Assoc; 2009 Dec; 102(12):351-3. PubMed ID: 20131730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.